Datameds Ai revenue was $14.03M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $1.6M, down 6.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MEDS annual revenue was $23.3M, with 28.7% growth year-over-year.
MEDS past revenue growth
How has MEDS's revenue growth performed historically?
Datameds Ai (NASDAQ: MEDS) reported Q1 2026 revenue of $1.56 million up 85.64% year over year. In the same quarter last year, Datameds Ai's revenue was $10.86 million.
What was Datameds Ai's revenue in 2025?
Datameds Ai's annual revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
How much does Datameds Ai make in a day?
Based on Datameds Ai annual revenue for the past three years, MEDS makes an average of $68,173.00 per day.
What was Datameds Ai's annual revenue growth in the past year?
As of Q3 2026, Datameds Ai's revenue has grown -51.59% year over year. This is 70.36 percentage points lower than the US Pharmaceutical Retailers industry revenue growth rate of 18.76%. Datameds Ai's revenue in the past year totaled $14.03 million.
How much does Datameds Ai make in a year?
Datameds Ai's revenue by year for the past three years is:
Datameds Ai's revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
Datameds Ai's annual revenue for Dec 31, 2024 was $18.13 million, a 45.37% decrease from 2023.
Datameds Ai's annual revenue for 2023 was $33.18 million, a 4.06% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.